<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Diverse HLA-I Peptide Repertoires of the APC Lines MUTZ3-Derived Immature and Mature Dendritic Cells and THP1-Derived Macrophages</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Wainaina</forename><surname>Lydon</surname></persName>
						</author>
						<author>
							<persName><surname>Nyambura</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Klinische Forschergruppe Tumorimmunologie</orgName>
								<orgName type="department" key="dep2">Klinik f€ ur Dermatologie, Venerologie and Allergologie</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<postCode>10098</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Institut f€ ur Biologie</orgName>
								<orgName type="department" key="dep2">Lebenswissenschaftliche Fakulta ¨t</orgName>
								<orgName type="institution">Humboldt Universita ¨t zu Berlin</orgName>
								<address>
									<postCode>10115</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Saulius</forename><surname>Jarmalavicius</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Klinische Forschergruppe Tumorimmunologie</orgName>
								<orgName type="department" key="dep2">Klinik f€ ur Dermatologie, Venerologie and Allergologie</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<postCode>10098</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Renato</forename><surname>Brito Baleeiro</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Klinische Forschergruppe Tumorimmunologie</orgName>
								<orgName type="department" key="dep2">Klinik f€ ur Dermatologie, Venerologie and Allergologie</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<postCode>10098</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Peter</forename><surname>Walden</surname></persName>
							<email>peter.walden@charite.de</email>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Klinische Forschergruppe Tumorimmunologie</orgName>
								<orgName type="department" key="dep2">Klinik f€ ur Dermatologie, Venerologie and Allergologie</orgName>
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<postCode>10098</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>Prof</roleName><forename type="first">Klinik</forename><forename type="middle">Peter</forename><surname>Walden</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Venerologie</forename><surname>F€ Ur Dermatologie</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution">The American Association of Immunologists, Inc</orgName>
								<address>
									<addrLine>Suite 650</addrLine>
									<postCode>1451, 20852</postCode>
									<settlement>Rockville Pike, Rockville</settlement>
									<region>MD</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="institution">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<address>
									<addrLine>Charite ´platz 1</addrLine>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Diverse HLA-I Peptide Repertoires of the APC Lines MUTZ3-Derived Immature and Mature Dendritic Cells and THP1-Derived Macrophages</title>
					</analytic>
					<monogr>
						<idno type="ISSN">0022-1767</idno>
					</monogr>
					<idno type="MD5">1D3EF3AAC065294BEAE1D8C9F48AC8A3</idno>
					<idno type="DOI">10.4049/jimmunol.1600762</idno>
					<note type="submission">Received for publication April 29, 2016. Accepted for publication July 15, 2016.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:46+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>0000-0003-2197-6048 (L.W.N.)</term>
					<term>0000-0001-7568-7570 (R.B.B.)</term>
					<term>0000-0002-8986-3667 (P.W.) DC, dendritic cell</term>
					<term>HLA-I, HLA class I</term>
					<term>iDC, immature DC</term>
					<term>IEDB, Immune Epitope Database</term>
					<term>LC, liquid chromatography</term>
					<term>mDC, mature DC</term>
					<term>MHC II, MHC class II</term>
					<term>MS, mass spectrometry</term>
					<term>MS/MS, tandem MS</term>
					<term>MUTZ3 iDC, MUTZ3-derived iDC</term>
					<term>MUTZ3 mDC, MUTZ3-derived mDC</term>
					<term>TFA, trifluoroacetic acid</term>
					<term>THP1MF, THP1-derived macrophage</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Dendritic cells (DCs) and macrophages are specialized APCs that process and present self-Ags for induction of tolerance and foreign Ags to initiate T cell-mediated immunity.</s><s>Related to differentiation states they have specific phenotypes and functions.</s><s>However, the impact of these differentiations on Ag processing and presentation remains poorly defined.</s><s>To gain insight into this, we analyzed and compared the HLA-I peptidomes of MUTZ3-derived human immature and mature DC lines and THP1-derived macrophages by liquid chromatography tandem mass spectrometry.</s><s>We found that the HLA-I peptidomes were heterogeneous and individualized and were dominated by nonapeptides with similar HLA-I binding affinities and anchor residues.</s><s>MUTZ3-derived DCs and THP1-derived macrophages were able to sample peptides from source proteins of almost all subcellular locations and were involved in various cellular functions in similar proportion, with preference to proteins involved in cell communication, signal transduction, protein metabolism, and transcription factor/regulator activity.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>D</head><p><s>endritic cells (DCs) and macrophages are closely related immune cells with a central role in the defense against invading pathogens and with comparable gene expression profiles <ref type="bibr" target="#b0">(1)</ref>.</s><s>They are often the first to encounter, identify, engulf, digest, and present the products of invading pathogens on their cell surface to T lymphocytes using MHC molecules <ref type="bibr" target="#b1">(2)</ref><ref type="bibr" target="#b2">(3)</ref><ref type="bibr" target="#b3">(4)</ref><ref type="bibr" target="#b4">(5)</ref>.</s><s>However, despite these similarities, specific phenotypic and functional differences exist.</s><s>Immature DCs (iDC) are highly endocytic, have high decay kinetics of specific MHC-peptide complexes, express low levels of MHC class II (MHC II) and T cell costimulatory molecules such as CD40, CD80, and CD86, and cannot activate naive T cells, whereas the mature DCs (mDC) are lowly endocytic, have low decay kinetics of specific MHC peptide complexes, express higher levels of increased MHC II and T cell costimulatory molecules, and activate naive T cells <ref type="bibr" target="#b5">(6,</ref><ref type="bibr" target="#b6">7)</ref>.</s><s>Macrophages are highly endocytic, express higher levels of MHC II, and do not prime T cells response against pathogen <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9)</ref>.</s></p><p><s>In APCs such as the DCs and macrophages, heterogeneous intracellular pathways and mechanisms are responsible for generating complexes of MHC I and II molecules with peptides.</s><s>For the MHC Ipeptide complexes, endogenous or viral proteins in the cytosol are processed through the proteasome, transported into the endoplasmic reticulum through the TAP, loaded onto MHC I molecules, and then transported through the Golgi apparatus and exocytic vesicles to the cell surface for presentation to CD8 + T cells <ref type="bibr" target="#b9">(10)</ref>.</s><s>The collection of peptides presented by the MHC molecules at the cell surface is termed the peptidome or ligandome.</s><s>The peptidome is influenced by the expression and rate of degradation of the source proteins, efficiency of peptide transport by TAP into the endoplasmic reticulum and subsequent loading onto MHC molecules, the binding affinities of the individual peptides to the presenting MHC molecules <ref type="bibr" target="#b10">(11)</ref><ref type="bibr" target="#b11">(12)</ref><ref type="bibr" target="#b12">(13)</ref>, and the decay kinetics of specific MHC-peptide complexes <ref type="bibr" target="#b13">(14)</ref>.</s></p><p><s>Cytokine-dependent CD34 + human acute myeloid leukemia cell line (MUTZ3)-derived DCs are similar to human DCs in many respects, such as a similar expression profile both in the immature and the mature forms <ref type="bibr" target="#b14">(15,</ref><ref type="bibr" target="#b15">16)</ref>, Ag processing and presentation, and ability to induce specific T cell proliferation <ref type="bibr" target="#b16">(17)</ref>.</s><s>Human monocytic leukemia cell line THP1-derived macrophages (THP1MF), in contrast, are similar to native monocyte-derived macrophages in several aspects including differentiation and phagocytosis <ref type="bibr" target="#b17">(18)</ref><ref type="bibr" target="#b18">(19)</ref><ref type="bibr" target="#b19">(20)</ref>.</s><s>The MUTZ3-derived DCs and THP1MF have been extensively used as models for studying human DC and macrophage immune functions <ref type="bibr" target="#b6">(7,</ref><ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b20">21)</ref>, and could serve to study and compare the peptidomes of DCs at different states and macrophages to gain insights into how different differentiations impact Ag processing and presentation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell lines</head><p><s>The commercially acquired human myeloid leukemia-derived cell line MUTZ3 (DMSZ, Braunschweig, Germany) was grown in a-MEM medium (Life Technologies, Grand Island, NY), supplemented with 10% conditioned medium from bladder carcinoma cell line 5637, 20% heatinactivated bovine calf serum (Biochrom, Berlin, Germany), 100 mg/ml streptomycin, 50 mM 2-ME, and 100 U/ml penicillin at 37˚C under 8% CO 2 .</s><s>The acute monocytic leukemia-derived human cell line THP1 (ATCC TIB-202) was grown in RPMI 1640 medium (Invitrogen, Karlsruhe, Germany) supplemented with 10% heat-inactivated bovine calf serum (Biochrom) and 1% streptomycin-penicillin at 37˚C under 8% CO 2 .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Generation of iDC, mDC, and macrophages</head><p><s>To generate the MUTZ3-derived iDC (MUTZ3 iDC), we differentiated MUTZ3 cells for 7 d in the presence 20 ng/ml recombinant human IL-4 (Peprotech, Rocky Hill, NJ), 100 ng/ml recombinant human GM-CSF (Genzyme, Cambridge, MA), and 2.5 ng/ml recombinant human TNF-a (Strathmann Biotech, Hamburg, Germany) minus the conditioned medium from the 5637 cell line.</s><s>The cytokines were refreshed at day 3.</s><s>Further differentiation to MUTZ3-derived mDC (MUTZ3 mDC) was achieved by addition of 10 ng/ml LPS (Sigma-Aldrich, Germany) at day 7 and culturing for additional 48-72 h.</s><s>To generate the THP1MF, we differentiated THP1 cells in the presence of 50 ng/ml PMA (Sigma, Steinheim, Germany) for 48 h.</s><s>Subsequently, for liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis, the MUTZ3 iDC, MUTZ3 mDC, and THP1MF cells were harvested by 10-min centrifugation at 800 3 g, shock-frozen in liquid nitrogen, and stored as pellets at 280˚C.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Phenotype analysis by flow cytometry</head><p><s>DC and macrophage phenotypes were assessed by flow cytometry.</s><s>MUTZ3 iDC and MUTZ3 mDC were stained with fluorochrome-labeled mAbs against CD80, CD83, CD40, CD86, HLA-ABC, HLA-DR (BD Biosciences, Heidelberg, Germany), and HLA-A2 (BioLegend, Eching, Germany), THP1MФ against HLA-ABC (BD Biosciences) and HLA-DR (Bio-Legend).</s><s>The expression of these markers on the surface of the DCs and THP1MФ was determined with a FACSCalibur flow cytometer (Becton Dickinson, Heidelberg, Germany); the data were processed and analyzed using CellQuest (Becton Dickinson) and WinMDi 2.9 (Purdue University) software, respectively.</s><s>The macrophage phenotype was also confirmed by adherence of THP1MF to the cell culture flask.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Isolation and purification of MHC I-presented peptides</head><p><s>MHC I molecules were isolated as described in detail elsewhere <ref type="bibr" target="#b21">(22,</ref><ref type="bibr" target="#b22">23)</ref>.</s><s>In brief, cells were lysed in 20 mM of Tris-HCl buffer, pH 7.4, 0.3% CHAPS, 0.2% Nonidet P-40, 145 mM of NaCl, 1 mM of EDTA, and 1 mM of Pefabloc.</s><s>Lysates were ultracentrifugated for 1 h at 100,000 3 g and the supernates passaged through a column with mAb of irrelevant specificity followed by a column with the monoclonal anti-human HLA-I Ab W6/32, both coupled to activated CH Sepharose (Amersham Biosciences, Uppsala, Sweden) as per manufacturer's protocol.</s><s>After adsorption of the proteins, the anti-human HLA-I column was washed with the following in descending order: 20 mM of Tris, 145 mM of NaCl, pH 7.4 (TBS), 0.3% CHAPS in TBS, TBS, 0.3% b-octylglycoside in TBS, TBS, and finally with ultrapure water.</s><s>HLA-I peptide complexes were eluted from the column with 0.7% trifluoroacetic acid (TFA) in ultrapure water.</s><s>High molecular mass components were separated from peptides by centrifugal ultrafiltration using a 3-kDa molecular mass cutoff (Centricon; Millipore, Schwalbach, Germany).The filtrates were fractionated on a Smart HPLC system (Amersham Biosciences, Freiburg, Germany) using a reverse-phase column mRPC C2/C18, SC2.1/10 (Amersham Biosciences) and an acetonitrile gradient of 5-90% of B (solvent B: 90% of acetonitrile, 0.1% TFA; solvent A: 0.1% TFA in ultrapure water).</s><s>The fractions obtained were lyophilized and redissolved in 0.1% TFA 2% acetonitrile for LC-MS/MS.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>LC-MS/MS analysis of HLA-I ligands</head><p><s>The peptide fractions were analyzed by reverse-phase LC using the Ultimate 3000 nano-HPLC system (Dionex, Darmstadt, Germany) coupled online to MicrOTOF-Q ESI-QTOF mass spectrometer (Bruker Daltonics, Bremen, Germany).</s><s>Peptide fractions were loaded onto a C18 precolumn at a flow rate of 20 ml/min in 98% solvent A (2% acetonitrile, 0.05% TFA) for 5 min and then onto a PepMap nano-HPLC column (75 mm 3 15 cm inner dimensions) at a flow rate of 220 nl/min and 2% solvent B (100% acetonitrile, 0.1% TFA) and 98% solvent A. A gradient of 5-60% of B over 60 min, then 60-90% of B over 5 min, and finally 90% of B for 5 min was used to elute the peptides.</s><s>The MicrOTOF-Q ESI-QTOF mass spectrometer was controlled by MicrOTOF control software, version 2.2 (Bruker Daltonics) and operated in a data-dependent mode.</s><s>Fragmentation of peptides was done on the five most intensive signals using optimized collision energy.</s><s>A dynamic exclusion time of 1 min was used to avoid repeated fragmentation of the most abundant precursors.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data processing and analysis</head><p><s>The processing of the MS and MS/MS spectra was done using Data Analysis 3.4 and Biotools 3.1 software (Bruker Daltonics).</s><s>The peptides were identified by a local MASCOT server (version 2.2), using the Swissprot databank version 56.3 for human proteins (20,408 entries), a precursor mass tolerance of 50 ppm, and 100 ppm for MS/MS, and oxidation of methionine as possible modification.</s><s>For each peptide-spectrum match, candidate sequences were validated using a statistical evaluation 210logP, where logP is the logarithm to the base 10 of P (p , 0.05) as the absolute probability.</s><s>Further validation of the identified peptides on the basis of de novo sequencing was done using the Sequit software <ref type="bibr" target="#b23">(24)</ref> and by manual inspection of the peptide-spectrum.</s><s>The protein sequence, protein ID, and gene symbol for proteomic data analyses were extracted from Uniprot database <ref type="bibr" target="#b24">(25)</ref>.</s><s>The human protein reference database ( <ref type="formula">26</ref>) was used to classify proteins according to their subcellular localizations and biological function.</s><s>HLA-I assignment of the peptides was done on the basis of canonical binding motifs, using SYFPEITHI <ref type="bibr" target="#b26">(27)</ref> and Immune Epitope Database (IEDB) <ref type="bibr" target="#b28">(28,</ref><ref type="bibr" target="#b29">29)</ref>.Visualization of the binding motifs for HLA-A*02:01, HLA-A3, HLA-B44 molecules for the nonapeptides derived from the MUTZ3 iDC and MUTZ3 mDC, and HLA-A*02:01, HLA-C*03:03, and HLA-B*15:11 from THP1MF was done using sequence logos <ref type="bibr" target="#b30">(30,</ref><ref type="bibr" target="#b31">31)</ref>, and artificial neural networks <ref type="bibr" target="#b32">(32)</ref> were used to assign the HLA-I binding affinities to the peptides.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DC and macrophage phenotypes</head><p><s>After differentiation of MUTZ3 cell line to MUTZ3 iDC and MUTZ3 mDC their phenotypic status was determined by measuring the expression of DC maturation markers CD83, CD80, CD86, HLA-DR, HLA-ABC, and HLA-A*02:01 by flow cytometry.</s><s>The maturation markers were expressed in both MUTZ3 iDC and MUTZ3 mDC, to a slightly greater extent in the mature DC phenotype (Fig. <ref type="figure" target="#fig_0">1A</ref>).</s><s>The expression of these maturation markers in both DC phenotypes was in agreement with previous reports <ref type="bibr" target="#b16">(17,</ref><ref type="bibr" target="#b33">33)</ref>.</s><s>The differentiation of THP1 to macrophages was ascertained by the adherence of THP1MF to the surface of the cell culture Flask (Fig. <ref type="figure" target="#fig_0">1B</ref>) and expression of HLA-DR and HLA-ABC (Fig. <ref type="figure" target="#fig_0">1C</ref>).</s><s>HLA-B44, and HLA-B56; THP1MF express HLA-A*02:01, HLA-C*03:03, and HLA-B*15:11 <ref type="bibr" target="#b16">(17,</ref><ref type="bibr" target="#b34">(34)</ref><ref type="bibr" target="#b35">(35)</ref><ref type="bibr" target="#b36">(36)</ref>.</s><s>In reference to HLA-A*02: 01, a total of 77, 99, and 122 HLA-A*02:01-restricted peptides were identified from MUTZ3 iDC, MUTZ3 mDC, and THP1MF, respectively.</s><s>Only 12 and 18 of these peptides were found to be shared between MUTZ3 iDC and MUTZ3 mDC, 8 and 13 between THP1MF and MUTZ3 iDC, 8 and 11 between THP1MF and MUTZ3 mDC, and 2 among MUTZ3 iDC, MUTZ3 mDC, and THP1MF, based on peptide sequences, and precursor peptide mass signals and retention time, respectively.</s><s>In reference to the source proteins of the identified peptides, 64 source proteins were found to be shared between the MUTZ3 iDC and MUTZ3 mDC, 10 among THP1MF, MUTZ3 iDC, and MUTZ3 mDC, 15 between THP1MF and MUTZ3 iDC, and 15 between THP1MF and MUTZ3 mDC.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Naturally</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MHC I-bound peptide lengths</head><p><s>The MHC I-bound peptide lengths in both DCs and the macrophage phenotypes were dominated by nanopeptides with 55-57% of all the identified peptides.</s><s>The dominance of nanopeptides was also observed in the shared peptides between MUTZ3 iDC and MUTZ3 mDC, and in the HLA-A*02:01-bound peptides shared among the MUTZ3 DCs and THP1MF.</s><s>This dominance of nanopeptides has also been observed in other cell lines and patient tumor samples <ref type="bibr" target="#b37">(37)</ref><ref type="bibr" target="#b38">(38)</ref><ref type="bibr" target="#b39">(39)</ref><ref type="bibr" target="#b40">(40)</ref>, and indicates that nine amino acids is the optimum length for MHC I-binding peptides.</s><s>Decapeptides were the second most dominant and constituted 22 and 25% for MUTZ3 iDC and MUTZ3 mDC and 12% for THP1.</s><s>Undecapeptides and larger peptides, in contrast, were ,2% in both MUTZ3 iDC and MUTZ3 mDC and ,6% in THP1MF (Fig. <ref type="figure" target="#fig_2">2</ref>).</s><s>The percentage of undecapeptides was very similar between the MUTZ3 DCs, as compared with those of THP1MF, whereas the share of decapeptides among all HLA-I-bound peptides from THP1MF was only half of what was found for the MUTZ3 DCs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HLA-I allomorph assignment and binding affinities</head><p><s>We used canonical peptide binding motifs listed in the SYFPEITHI database <ref type="bibr" target="#b26">(27)</ref> and Immune Epitope Database <ref type="bibr" target="#b28">(28,</ref><ref type="bibr" target="#b29">29)</ref> for the respective HLA-I to identify the MHC restriction of the peptides.</s><s>For MUTZ3 iDC, 70, 23, 4, and 1% of the peptides were assigned to HLA-B44, HLA-A*02:01, HLA-A3, and HLA-B56, respectively, and 48, 32, 13, and 5% to MUTZ3 mDC.</s><s>Approximately 2% of the peptides in both DC phenotypes were unassigned (Fig. <ref type="figure" target="#fig_3">3A</ref>).</s><s>In THP1MF, 40, 37, and 23% of the peptides were assigned to HLA-A*02:01, HLA-C*03:03, and HLA-B*15:11, respectively.</s><s>In both MUTZ3 DC phenotypes, the percentages of peptides assigned were in the order HLA-B44 $ HLA-A*02:01 $ HLA-A3 $ HLA-B56.</s><s>To determine what percentage of the identified MHC-1 peptides (8-14mers) had biologically significant binding affinity, we used artificial neural networks in IEDB <ref type="bibr" target="#b28">(28,</ref><ref type="bibr" target="#b29">29)</ref> and applied a binding affinity IC 50 threshold of 500 nM, which was established previously for known T cells epitopes and had been shown to correlate with immunogenicity <ref type="bibr" target="#b41">(41)</ref>.</s><s>In MUTZ3 DCs, the percentage of peptides that were within this threshold was relatively the same across all the alleles, and the difference was seen only in HLA-A*02:01 peptides, where the percentages were higher in MUTZ3 iDC (82%) as compared with MUTZ3 mDC (60%).</s><s>No peptides were within this threshold for HLA-B56.</s><s>In THP1MF the highest percentage of peptides was seen in HLA-A*02:01 (52%) (Fig. <ref type="figure" target="#fig_3">3B</ref>).</s><s>The cumulative percentage frequencies for HLA-A*02:01 and HLA-B44 peptides in MUTZ3 DCs were the same, but there was a shift toward higher affinity peptides for HLA-A3 in MUTZ3 mDCs.</s><s>In reference to the HLA-A*02:01-bound peptides in MUTZ3 DCs and THP1MF, at IC 50 threshold of 100 nM the cumulative percentage frequencies were similar, and all were .82%</s><s>(Fig. <ref type="figure" target="#fig_3">3C</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Binding motifs for HLA-I molecules in MUTZ3 DCs and THP1MF</head><p><s>We further determined whether there was a particular preference for binding motifs in the nanopeptides from MUTZ3 iDC, MUTZ3 mDC, and THP1MF, using sequence logos <ref type="bibr" target="#b30">(30,</ref><ref type="bibr" target="#b31">31)</ref>.</s><s>The height of each column of letters is equal to the information content (in bits) at the given positions in the peptide sequence, and the relative height of each letter within each column is proportional to the frequency of the corresponding amino acid at that position.</s><s>The frequency of the primary anchor residues at position 2 and the C terminus in the HLA-A*02:01, HLA-A3, and HLA-B44 nonapeptides, in both DC phenotypes, was essentially the same, with only minor differences in the order and identity of residues at position 2 and the C-terminal positions.</s><s>There was a high frequency of L and M at position 2, and V and L at C terminus for HLA-A*02:01-bound peptides with V more prominent in P9 in case of the mDCs versus iDCs, E at P2 and K at C terminus for HLA-A3 peptides, and aromatic amino acids at C terminus for HLA-B44-bound peptides (Fig. <ref type="figure" target="#fig_4">4</ref>).</s><s>In THP1MF the frequency of L and I was high at P2, V and L at C terminus for HLA-A*02:01-bound peptides, A and Y at position 2 and L and F at C terminus for HLA-C*03:03-bound peptides, and P at position 2 and Y and F at the C terminus for HLA-B*15:11-bound peptides (Fig. <ref type="figure" target="#fig_4">4</ref>).</s><s>The frequency of the primary anchor residues at position 2 and the C terminus of the HLA-A*02:01-bound peptides in both DCs and THP1MF was essentially the same, and only minor differences were observed in the order and identity of residues at position 2 and the C terminus.</s><s>The human protein reference database was used to assign the subcellular location of the source proteins of the HLA-I-bound peptides from MUTZ3 DCs and THP1MF.</s><s>The nucleus, cytoplasm, and plasma membrane were the dominant subcellular locations of the source proteins (Fig. <ref type="figure">5</ref>).</s><s>Together, they accounted for 72, 70, and 64% of all the source proteins in MUTZ3 iDC, MUTZ3 mDC, and THP1MF, respectively.</s><s>Approximately half of this percentage was solely from the nucleus, which accounted for .30% of all the source proteins.</s><s>The other subcellular locations, that is, endoplasmic reticulum, ribosome, membrane, nucleolus, mitochondrion, cytoskeleton, extracellular, Golgi apparatus, lysosome, endosome, exosome, microsome, and cytosol, all together accounted for 24, 24, and 31% of the source proteins in MUTZ3 iDC, MUTZ3 mDC, and THP1MF, respectively.</s><s>The subcellular location of 4, 6, and 5% of the source proteins in the respective cells was unknown (Fig. <ref type="figure">5</ref>).</s><s>No source protein was found in intracellular vesicle compartments of MUTZ3 iDC, in the exosome and microsome compartments of the MUTZ3 mDC, and in the microsome and nucleolus compartments of THP1MF.</s></p><p><s>The source proteins were further evaluated for their biological and molecular functions, again using the human protein reference database <ref type="bibr" target="#b25">(26)</ref>.</s><s>Although source proteins possessed multiple biological functions, a vast majority of them in MUTZ3 iDC, MUTZ3 mDC, and THP1MF were involved in cell communication/signal transduction (15, 18, 16%), protein metabolism <ref type="bibr">(15, 12, 19%)</ref>, and transcription factor activity/regulator activity <ref type="bibr">(12, 12, 11%)</ref>.</s><s>The remaining were involved in transport (6, 8, 8%), metabolism, energy pathways (8, 8, 6%), cell growth and/or maintenance <ref type="bibr">(8, 7, 10%)</ref>, immune response (5, 3, 2%), DNA binding (4, 2, 3%), and RNA binding <ref type="bibr">(5, 3, 5%)</ref>.</s><s>Some were involved in other functions <ref type="bibr">(13, 7, 5%)</ref>, and some (8, 14, 7%) with no known biological functions.</s><s>In reference to shared source proteins between MUTZ3 iDC and MUTZ3 mDC, these were involved in all biological functions, but mostly in cell growth and/or maintenance (14%) and cell communication/signal transduction (14%) (Fig. <ref type="figure" target="#fig_5">6</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The total number of HLA-I-restricted peptides and source proteins identified in MUTZ3 DCs and THP1MF was about the same, and they were heterogeneous and individualized, despite the MUTZ3 iDC and mDC expressing the same HLA-I alleles and sharing one with THP1MF.</s><s>Only a small fraction of HLA-I peptides and source proteins was found to be shared between the MUTZ3 DCs, and among the MUTZ3 DCs and the THP1MF.</s><s>The heterogeneity and individualization was slightly higher for the HLA-I-bound peptides than for the source proteins, as the number of shared source proteins was slightly higher compared with those of the HLA-I peptides.</s><s>This has been observed also in other human cell lines and tumor samples such as melanoma <ref type="bibr" target="#b37">(37,</ref><ref type="bibr" target="#b38">38,</ref><ref type="bibr" target="#b40">40)</ref> and depicts differences in the Ag processing and presentation in the two MUTZ3 DC differentiation states and THPMF.</s></p><p><s>Despite the fact that the HLA-I peptides and the source proteins were heterogeneous and individualized, a number of similarities were observed.</s><s>First, in MUTZ3 DCs and THP1MF, nanopeptides were the most dominant and constituted 50% of all the identified peptides, followed by decapeptides with ∼25% of peptides in MUTZ3 DCs, compared with 12% in THP1MF.</s><s>Second, in <ref type="bibr">FIGURE 5</ref>. Subcellular location of the source proteins.</s><s>The subcellular locations of the source proteins of the HLA-I-bound peptides from MUTZ3 iDC, MUTZ3 mDC, and THP1MF identified by LC-MS/MS were assigned using the Human Protein Reference Database.</s><s>both MUTZ3 DCs, the percentage of peptides identified by LC-MS/MS declined in the order HLA-B44 $ HLA-A*02:01 $ HLA-A3 $ HLA-B56, and the specific HLA-I peptides had similar dominant anchor residues at position 2 and the C terminus with only minor differences in order and identity.</s><s>This similarity in the anchor motifs was also observed in HLA-A*02:01-bound peptides from MUTZ3 DCs and THP1MF.</s><s>The numbers of HLA-B56 peptides were too low for any conclusive comparison in the anchor motifs.</s><s>Third, in both MUTZ3 DC variants, the HLA-A*02:01-associated peptides were stronger HLA-I binders followed by HLA-B44, HLA-A3, and lastly HLA-B56.</s><s>For HLA-B56, no peptides were predicted for the IC 50 (500 nM) threshold, suggesting that HLA-B56-associated peptides are low-affinity binders <ref type="bibr" target="#b42">(42)</ref>.</s></p><p><s>Similarities were also observed in MUTZ3 DCs and THP1MF, the subcellular locations and molecular functions of HLA-I peptides source proteins.</s><s>First, the source proteins were derived from almost all subcellular locations, with the nucleus, cytoplasm, plasma membrane, and endoplasmic reticulum the most dominant (Fig. <ref type="figure">5</ref>), which is similar for the HLA-I peptidome of melanoma tumor samples reported earlier <ref type="bibr" target="#b37">(37,</ref><ref type="bibr" target="#b38">38)</ref>, but different for other human samples such as the B lymphoblastoid cell line, where no source proteins from plasma membrane were found <ref type="bibr" target="#b39">(39)</ref>, and multiple sclerosis autopsy samples, where cytoplasm and plasma membrane were the most dominant, 34 and 24%, respectively <ref type="bibr" target="#b40">(40)</ref>.</s><s>Second, the source proteins were involved in various molecular functions but especially in cell communication/signal transduction, protein metabolism, and transcription factor activity/regulator activity, and the proportion of source proteins per molecular function was similar.</s><s>In contrast, in the B lymphoblastic cell line 721.221, the source proteins were dominantly involved in declining prominence in metabolism, cell growth and/or maintenance, cell communication, and stress response <ref type="bibr" target="#b39">(39)</ref>, and in multiple sclerosis autopsy samples, they were dominantly involved in cellular assembly and organization, nervous system development and function, cellular growth, and proliferation <ref type="bibr" target="#b40">(40)</ref>.</s><s>The similarities in source protein peptide sampling in MUTZ3 DCs and THP1MF, although unconfirmed, would imply similarities in protein turnover, because protein turnover correlates with source protein peptide sampling <ref type="bibr" target="#b43">(43,</ref><ref type="bibr" target="#b44">44)</ref>.</s></p><p><s>Further evaluation of the HLA-I peptidome of MUTZ3 DCs and THP1MF in the presence of a pathogen would be vital to fully understand the impact of different physiological and pathological states on Ag processing and presentation, and thereby on their immunogenicity of the cells, and the specificities of the resulting T cell responses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosures</head><p><s>The authors have no financial conflicts of interest.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIGURE 1 .</head><label>1</label><figDesc><div><p><s>FIGURE 1. DC and macrophage differentiations.</s><s>(A) A representative of analysis of MUTZ3 iDC and MUTZ3 mDC phenotypes.</s><s>MUTZ3 iDCs were generated by culturing the MUTZ3 cells as detailed in Materials and Methods, after which the MUTZ3 mDC were generated by addition of LPS.</s><s>Expression levels of CD80, CD86, CD83, HLA-ABC, HLA-A*02:01, and HLA-DR on the surface of both MUTZ3 iDC and MUTZ3 mDC were analyzed by flow cytometry.</s><s>(B) Acquisition of an adherent phenotype by THP1 upon differentiation to THP1MF after exposure to PMA. (C) Expression levels of HLA-DR and HLA-ABC in THP1MF.</s></p></div></figDesc><graphic coords="3,44.50,358.92,494.95,336.53" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>presented HLA class I ligands of MUTZ3 iDC, MUTZ3 mDC, and THP1MF MUTZ3 iDC, MUTZ3 mDC, and THP1MF cells were lysed, MHC I molecules were isolated by affinity chromatography, and peptides extracted from the MHC molecules were analyzed by LC-MS/MS.</s><s>The sequences of a total of 327, 301, and 347 HLA class I (HLA-I)-bound peptides were identified from 297, 273, and 282 source proteins in MUTZ3 iDC, MUTZ3 mDC, and THP1MF, respectively (Supplemental Table I).</s><s>Although the MUTZ3 iDC and MUTZ3 mDC are derived from the same cell line and have the same HLA-I alleles, only 59 and 74 HLA-I peptides sequences were found to be shared between them based on peptide sequences, and precursor peptide mass signals and retention time, respectively.</s><s>MUTZ3 iDC and MUTZ3 mDC express HLA-A*02:01, HLA-A3,</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIGURE 2 .</head><label>2</label><figDesc><div><p><s>FIGURE 2. MHC I-peptide lengths in MUTZ3 iDC, MUTZ3 mDC, and THP1MF.</s></p></div></figDesc><graphic coords="4,239.81,394.41,299.44,352.35" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIGURE 3 .</head><label>3</label><figDesc><div><p><s>FIGURE 3. HLA-I restriction and binding affinities.</s><s>(A) MHC restriction of HLA-I-bound peptides from immature and mature DC phenotypes were assigned using the canonical binding motif according to SYFPEITHI and IEDB.</s><s>(B) Percentage of MUTZ3 iDC and MUTZ3 mDC and THP1MF HLA-I peptides with an IC 50 #500 nM.</s><s>(C) Cumulative percent of MHC I peptides in MUTZ3 iDC and MUTZ3 mDC and THP1MF at an IC 50 threshold of 500 nM.</s></p></div></figDesc><graphic coords="5,43.88,402.75,496.02,303.19" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>FIGURE 4 .</head><label>4</label><figDesc><div><p><s>FIGURE 4. Binding motifs for HLA-I molecules in MUTZ3 DCs and THP1MF.</s><s>Sequence logos displaying the binding motifs for HLA-A*02:01, HLA-A3-, and HLA-B44-bound nonapeptides from MUTZ3 iDC and MUTZ3 mDC, and HLA-A*02:01, HLA-C*03:03-, and HLA-B*15:11-bound nonapeptides from THP1MF.</s><s>The height of each column of letters is equal to the information content (in bits) at the given sequence positions, whereas the relative height of each letter within the columns is proportional to the frequency of the corresponding amino acid at that position.</s></p></div></figDesc><graphic coords="6,101.88,241.97,382.60,464.03" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>FIGURE 6 .</head><label>6</label><figDesc><div><p><s>FIGURE 6. Biological and molecular functions of the source proteins.</s><s>The biological and molecular functions of the source proteins of the HLA-I-bound peptides from MUTZ3 iDC, MUTZ3 mDC, and THP1MF were assigned using the Human Protein Reference Database.</s></p></div></figDesc><graphic coords="8,238.85,51.02,300.52,402.12" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="7,238.56,400.65,299.44,346.11" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">by guest on May 17, 2022 http://www.jimmunol.org/ Downloaded from</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">HLA-I PEPTIDOME OF APC LINES by guest on May 17, 2022 http://www.jimmunol.org/ Downloaded from</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">The Journal of Immunology</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">http://www.jimmunol.org/ Downloaded from</note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites</title>
		<author>
			<persName><forename type="first">D</forename><surname>Chaussabel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Semnani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Mcdowell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sacks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Nutman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="672" to="681" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Cross-presentation: dendritic cells and macrophages bite off more than they can chew</title>
		<author>
			<persName><forename type="first">S</forename><surname>Brode</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Macary</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunology</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="345" to="351" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Nathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Wiebe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">Y</forename><surname>Rubin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Exp. Med</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="670" to="689" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Drinking a lot is good for dendritic cells</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Norbury</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunology</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="443" to="451" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Dendritic cells: specialized and regulated antigen processing machines</title>
		<author>
			<persName><forename type="first">I</forename><surname>Mellman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Steinman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="255" to="258" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Reactive oxygen species production in the phagosome: impact on antigen presentation in dendritic cells</title>
		<author>
			<persName><forename type="first">F</forename><surname>Kotsias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Amigorena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Savina</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antioxid. Redox Signal</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="714" to="729" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Plasmacytoid dendritic cells are productively infected and activated through TLR-7 early after arenavirus infection</title>
		<author>
			<persName><forename type="first">M</forename><surname>Macal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kunz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Flavell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Harker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Host Microbe</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="617" to="630" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>Zu ´n ˜iga</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Nitric oxide and macrophage function</title>
		<author>
			<persName><forename type="first">J</forename><surname>Macmicking</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">W</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Nathan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu. Rev. Immunol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="323" to="350" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Immune suppression by myeloid cells in HIV infection: new targets for immunotherapy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Mehraj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Jenabian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Vyboh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Routy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Open AIDS J</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="66" to="78" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Major histocompatibility complex class I-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase</title>
		<author>
			<persName><forename type="first">T</forename><surname>Saric</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Beninga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Graef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">N</forename><surname>Akopian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Rock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Goldberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="page" from="36474" to="36481" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Yewdell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Bennink</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu. Rev. Immunol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="51" to="88" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways</title>
		<author>
			<persName><forename type="first">´</forename><surname>Gromme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Neefjes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Immunol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="181" to="202" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Major histocompatibility complex class I-restricted antigen processing and presentation</title>
		<author>
			<persName><forename type="first">L</forename><surname>Van Kaer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tissue Antigens</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Extended presentation of specific MHC-peptide complexes by mature dendritic cells compared to other types of antigen-presenting cells</title>
		<author>
			<persName><forename type="first">D</forename><surname>Zehn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Reiter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Walden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Immunol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="1551" to="1560" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">The global transcriptional maturation program and stimuli-specific gene expression profiles of human myeloid dendritic cells</title>
		<author>
			<persName><forename type="first">D</forename><surname>Messmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Messmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Chiorazzi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. Immunol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="491" to="503" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Global reprogramming of dendritic cells in response to a concerted action of inflammatory mediators</title>
		<author>
			<persName><forename type="first">M</forename><surname>Lindstedt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Johansson-Lindbom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Borrebaeck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. Immunol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1203" to="1213" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Masterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Sombroek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>De Gruijl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Graus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Van Der</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Vliet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Lougheed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Van Den Eertwegh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Pinedo</surname></persName>
		</author>
		<author>
			<persName><surname>Scheper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="701" to="703" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)</title>
		<author>
			<persName><forename type="first">S</forename><surname>Tsuchiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yamabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yamaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Konno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tada</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Cancer</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="171" to="176" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3</title>
		<author>
			<persName><forename type="first">H</forename><surname>Schwende</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fitzke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ambs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dieter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Leukoc. Biol</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="555" to="561" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The identification of markers of macrophage differentiation in PMAstimulated THP-1 cells and monocyte-derived macrophages</title>
		<author>
			<persName><forename type="first">M</forename><surname>Daigneault</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Preston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Marriott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Whyte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Dockrell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">e8668</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Monocyte-derived dendritic cells as a model for the study of HIV-1 infection: productive infection and phenotypic changes during culture in human serum</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Mallon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Buck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Reece</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Crowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">U</forename><surname>Cameron</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="442" to="450" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Biochemical determination of natural tumor-associated T-cell epitopes</title>
		<author>
			<persName><forename type="first">R</forename><surname>Demine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sherev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Walden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Biotechnol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="71" to="78" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Testing the role of gp96 as peptide chaperone in antigen processing</title>
		<author>
			<persName><forename type="first">R</forename><surname>Demine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Walden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="page" from="17573" to="17578" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Sequit: software for de novo peptide sequencing by matrix-assisted laser desorption/ionization post-source decay mass spectrometry</title>
		<author>
			<persName><forename type="first">R</forename><surname>Demine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Walden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rapid Commun. Mass Spectrom</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="907" to="913" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">UniProt: a hub for protein information</title>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="D204" to="D212" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Human protein reference database-2006 update</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Mishra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Suresh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kumaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kannabiran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Suresh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shivakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Anuradha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Reddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Raghavan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="D411" to="D414" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">H</forename><surname>Rammensee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bachmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Emmerich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">A</forename><surname>Bachor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stevanovic</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">SYFPEITHI: database for MHC ligands and peptide motifs</title>
	</analytic>
	<monogr>
		<title level="j">Immunogenetics</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="213" to="219" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Reliable prediction of T-cell epitopes using neural networks with novel sequence representations</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nielsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lundegaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Worning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Lauemøller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lamberth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Buus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Brunak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Lund</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Protein Sci</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1007" to="1017" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lundegaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Lund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nielsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1397" to="1398" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">WebLogo: a sequence logo generator</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Crooks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Chandonia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Brenner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1188" to="1190" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Sequence logos: a new way to display consensus sequences</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Stephens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="6097" to="6100" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sidney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Guercio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Southwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ruppert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dahlberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Grey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Kubo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Immunol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="813" to="822" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Human dendritic cell line models for DC differentiation and clinical DC vaccination studies</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Santegoets</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Van Den Eertwegh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Van De Loosdrecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Scheper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>De Gruijl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Leukoc. Biol</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="1364" to="1373" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Constitutively active STAT5b induces cytokine-independent growth of the acute myeloid leukemiaderived MUTZ-3 cell line and accelerates its differentiation into mature dendritic cells</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Bontkes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Ruizendaal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Santegoets</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Scheper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>De Gruijl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Meijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hooijberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunother</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="188" to="200" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Increased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabine</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Ning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e70522</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Carrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">N</forename><surname>Kewalramani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virology</title>
		<imprint>
			<biblScope unit="volume">318</biblScope>
			<biblScope unit="page" from="17" to="23" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">High immunogenicity of the human leukocyte antigen peptidomes of melanoma tumor cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Jarmalavicius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Welte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Walden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">287</biblScope>
			<biblScope unit="page" from="33401" to="33411" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Exploration of peptides bound to MHC class I molecules in melanoma</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Pritchard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Hastie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Neller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Gorman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Hayward</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pigment Cell Melanoma Res</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="281" to="294" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Comprehensive analysis of the naturally processed peptide repertoire: differences between HLA-A and B in the immunopeptidome</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Schellens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hoof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Meiring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Spijkers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Poelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Van Gaans-Van Den Brink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Van Der Poel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Van Els</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Van Baarle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kesmir</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">e0136417</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients</title>
		<author>
			<persName><forename type="first">N</forename><surname>Fissolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Haag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>De Graaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Drews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stevanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Rammensee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Weissert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell. Proteomics</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="2090" to="2101" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity</title>
		<author>
			<persName><forename type="first">S</forename><surname>Paul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Weiskopf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Angelo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sidney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sette</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">191</biblScope>
			<biblScope unit="page" from="5831" to="5839" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides</title>
		<author>
			<persName><forename type="first">D</forename><surname>Gebreselassie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Spiegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vukmanovic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum. Immunol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="894" to="906" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bassani-Sternberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pletscher-Frankild</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell. Proteomics</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="658" to="673" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Reexamining class-I presentation and the DRiP hypothesis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Rock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Farfa ´n-Arribas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Colbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Goldberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Immunol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="144" to="152" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
